HOYA Corporation
Notice Regarding Transfer of Shares of HOYA Subsidiary MID Labs
All shares of MID Labs will be transferred to Bausch + Lomb. The transferee will hold an 88% stake, and HOYA Group expects the impact on consolidated results to be minor after the transfer. Agreement signing date is 2026-10-09, and share delivery date is 2026-11-02.
Key Figures
- Number of shares transferred: 3,648,539 shares
- Shares held after transfer: 0 shares
- Agreement signing date for transfer: 2026-10-09
AI要約
Overview of the Transaction
HOYA Corporation has decided to transfer all shares of its subsidiary Medical Instrument Development Laboratories, Inc. (MID Labs) to Bausch + Lomb Corporation, and has concluded the definitive agreement today. The transferee is Bausch + Lomb, and MID Labs will be outside the HOYA Group after the transfer. The share delivery is scheduled for 2026-11-02.
Financial and Business Impact and Outlook
The transfer is expected to have a minor impact on HOYA's consolidated results for the current fiscal year and is being implemented as part of the Group's business portfolio optimization and growth strategy. For MID Labs, recent financials for the past three years include net sales of 34 million USD (fiscal year ended March 2026), among others.
HOYA Corporation
Company overview · Stock price · Financial data · All IR